APOE and hepatocellular carcinoma: This strategy was originally developed in neurology in vitro(Chen et al. 2012), but it could be a replenishment in immunotherapy plan for HCC, after determining the genotype of apoE in patients, shedding light on personal and precise medicine for HCC.